Title : Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19.

Pub. Date : 2021 Aug 20

PMID : 34452053






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Receptor-Binding Domain (RBD) of the Spike (S) protein from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has glycosylation sites which can limit the production of reliable antigens expressed in prokaryotic platforms, due to glycan-mediated evasion of the host immune response. Polysaccharides surface glycoprotein Severe acute respiratory syndrome coronavirus 2
2 The Receptor-Binding Domain (RBD) of the Spike (S) protein from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has glycosylation sites which can limit the production of reliable antigens expressed in prokaryotic platforms, due to glycan-mediated evasion of the host immune response. Polysaccharides surface glycoprotein Severe acute respiratory syndrome coronavirus 2